A prospective , randomized study of @ patients , randomized into Group I ( Warfarin ) and Group II ( AAS ) , underwent total cavopulmonary shunt with extracardiac conduit , between @ and @ , with follow-up by clinical visits to evaluate side effects and adhesion .